RPG Life Sciences · NSE: RPGLIFE · BSE: 532983
Q3 FY19 results · Oct–Dec 2018
RPG Life Sciences reported revenue from operations of ₹90.97 crore and net profit of ₹5.28 crore for Q3 FY19 (Oct–Dec 2018), on a standalone basis.
| Item | Q3 FY19 | Q3 FY18 | YoY | Q2 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 90.97 | — | — | 90.50 | +0.5% |
| Other income | 0.02 | — | — | 0.06 | −66.7% |
| Total income | 90.99 | — | — | 90.56 | +0.5% |
| Profit before tax | 7.25 | — | — | 3.10 | +133.9% |
| Net profit for the period | 5.28 | — | — | 2.16 | +144.4% |
| EPS, basic (₹) | 3.19 | — | — | 1.31 | +143.5% |
| Net margin (%) | 5.8 | — | 2.4 |
Standalone
- Filed with BSE
- 06 Feb 2019, 15:18 IST
- Board meeting
- 05 Feb 2019
- Period
- 01 Oct 2018 to 31 Dec 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE